Slaney CY[Author] - Search Results

Year	Number of Results
2010	1
2011	2
2012	1
2013	3
2014	3
2015	7
2016	2
2017	4
2018	3
2019	3
2020	8
2021	6
2022	1
2023	2
2024	1

1

Cellular networks controlling T cell persistence in adoptive cell therapy.

Chan JD, Lai J, Slaney CY, Kallies A, Beavis PA, Darcy PK. Chan JD, et al. Among authors: slaney cy. Nat Rev Immunol. 2021 Dec;21(12):769-784. doi: 10.1038/s41577-021-00539-6. Epub 2021 Apr 20. Nat Rev Immunol. 2021. PMID: 33879873 Review.

2

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.

Chan JD, Scheffler CM, Munoz I, Sek K, Lee JN, Huang YK, Yap KM, Saw NYL, Li J, Chen AXY, Chan CW, Derrick EB, Todd KL, Tong J, Dunbar PA, Li J, Hoang TX, de Menezes MN, Petley EV, Kim JS, Nguyen D, Leung PSK, So J, Deguit C, Zhu J, House IG, Kats LM, Scott AM, Solomon BJ, Harrison SJ, Oliaro J, Parish IA, Quinn KM, Neeson PJ, Slaney CY, Lai J, Beavis PA, Darcy PK. Chan JD, et al. Among authors: slaney cy. Nature. 2024 May;629(8010):201-210. doi: 10.1038/s41586-024-07242-1. Epub 2024 Apr 10. Nature. 2024. PMID: 38600376

3

Challenges and Opportunities for Effective Cancer Immunotherapies.

Slaney CY, Kershaw MH. Slaney CY, et al. Cancers (Basel). 2020 Oct 28;12(11):3164. doi: 10.3390/cancers12113164. Cancers (Basel). 2020. PMID: 33126513 Free PMC article.

4

Cross-talk between tumors at anatomically distinct sites.

Oliver AJ, Darcy PK, Trapani JA, Kershaw MH, Slaney CY. Oliver AJ, et al. Among authors: slaney cy. FEBS J. 2021 Jan;288(1):81-90. doi: 10.1111/febs.15316. Epub 2020 Apr 21. FEBS J. 2021. PMID: 32248616 Free article. Review.

5

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.

Pappas EG, Kershaw MH, Slaney CY. Pappas EG, et al. Among authors: slaney cy. Cancers (Basel). 2023 Feb 19;15(4):1322. doi: 10.3390/cancers15041322. Cancers (Basel). 2023. PMID: 36831663 Free PMC article.

6

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.

Oliver AJ, Lau PKH, Unsworth AS, Loi S, Darcy PK, Kershaw MH, Slaney CY. Oliver AJ, et al. Among authors: slaney cy. Front Immunol. 2018 Jan 31;9:70. doi: 10.3389/fimmu.2018.00070. eCollection 2018. Front Immunol. 2018. PMID: 29445373 Free PMC article. Review.

7

Trafficking of T cells into tumors.

Slaney CY, Kershaw MH, Darcy PK. Slaney CY, et al. Cancer Res. 2014 Dec 15;74(24):7168-74. doi: 10.1158/0008-5472.CAN-14-2458. Epub 2014 Dec 4. Cancer Res. 2014. PMID: 25477332 Review.

8

Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new.

Slaney CY, Luo P, Kong FM, Guo L, Zhang J. Slaney CY, et al. Front Immunol. 2023 Jan 12;13:1129623. doi: 10.3389/fimmu.2022.1129623. eCollection 2022. Front Immunol. 2023. PMID: 36713443 Free PMC article. No abstract available.

9

CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer Treatment.

Slaney CY, Wang P, Darcy PK, Kershaw MH. Slaney CY, et al. Cancer Discov. 2018 Aug;8(8):924-934. doi: 10.1158/2159-8290.CD-18-0297. Epub 2018 Jul 16. Cancer Discov. 2018. PMID: 30012854 Review.

10

Chimeric antigen receptor T cell therapies for thoracic cancers-challenges and opportunities.

Chan JD, Harrison AJ, Darcy PK, Kershaw MH, Slaney CY. Chan JD, et al. Among authors: slaney cy. J Thorac Dis. 2020 Aug;12(8):4510-4515. doi: 10.21037/jtd.2020.03.34. J Thorac Dis. 2020. PMID: 32944365 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year